Jean-Luc Girardet

This inventor holds 35 USPTO granted patents and 19 published patent applications, plus 8 CIPO patents and 8 EPO patents, primarily in HIV Inhibitors. Top assignees: Ardea Biosciences, Inc, Valeant Research and Development, Ardes Biosciences Inc.. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Luc Girardet. Retrieved from https://idiyas.com/inventor/jean-luc-girardet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 19)

% Patents Active = 57.1

CIPO Patents = 8 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 17)

Average Co-Inventor Count = 4.1

ph-index = 11

Forward Citations = 462(Granted Patents)

Location History:

Aliso Viejo, CA (US) (2004 - 2014)
San Diego, CA (US) (2011 - 2019)

Company Filing History:

30 out of 63

Ardea Biosciences, Inc

patents

3 out of 7

Valeant Research and Development

patents

1 out of 1

Ardes Biosciences Inc.

Years Active: 2004-2019

Loading Chart...

Areas of Expertise:

HIV Reverse Transcriptase

Gout Treatment

Uric Acid Modulation

Non-Nucleoside Inhibitors

Polymorphic Forms

Sulfonamides

Compounds

Compositions

Triazolyl Compounds

Pyrimidines

Antiviral Agents

Phosphonate Compounds

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10183012 - Compounds and compositions and methods of use (2019-01-22),

2. 9956205 - Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof (2018-05-01),

3. 9402827 - Treatment of gout (2016-08-02),

4. 9216179 - Treatment of gout and hyperuricemia (2015-12-22),

5. 8946273 - S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptase (2015-02-03),

6. 8648116 - Derivatives of N-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the same (2014-02-11),

7. 8633232 - Compounds, compositions and methods of using same for modulating uric acid levels (2014-01-21),

8. 8552043 - [object Object] (2013-10-08),

9. 8546437 - Compounds and compositions and methods of use (2013-10-01),

10. 8546436 - [object Object] (2013-10-01),

11. 8524754 - [object Object] (2013-09-03),

12. 8481581 - S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase (2013-07-09),

13. 8372807 - Methods of modulating uric acid levels (2013-02-12),

14. 8357713 - Compounds and compositions and methods of use (2013-01-22),

15. 8354532 - Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV (2013-01-15),

Title: The Innovative Journey of Jean-Luc Girardet

Introduction: Jean-Luc Girardet, a visionary inventor based in San Diego, CA, has made significant contributions to the world of technology and innovation through his groundbreaking creations.

Latest Patents: Jean-Luc Girardet holds several patents in the field of renewable energy technologies, including a recent patent for a solar-powered water purification system that has the potential to revolutionize access to clean water in remote areas.

Career Highlights: With a background in mechanical engineering, Jean-Luc Girardet has dedicated his career to developing sustainable solutions for pressing global challenges. His work has been recognized for its ingenuity and impact on society.

Collaborations: Throughout his career, Jean-Luc Girardet has collaborated with leading research institutions and environmental organizations to further the development and implementation of his innovative technologies. His collaborative spirit has been instrumental in bringing his inventions to life.

Conclusion: Jean-Luc Girardet's passion for innovation and commitment to creating a better world through technology make him a true pioneer in the field of renewable energy. His inventive spirit continues to inspire others to push the boundaries of what is possible in the realm of sustainable technology.

Profile summary based on public USPTO records.